Cargando…

Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs

BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Marcio C, Stämpfli, Henry R, Arroyo, Luis G, Allen-Vercoe, Emma, Gomes, Roberta G, Weese, J Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323147/
https://www.ncbi.nlm.nih.gov/pubmed/25644524
http://dx.doi.org/10.1186/s12917-015-0335-7
_version_ 1782356501484011520
author Costa, Marcio C
Stämpfli, Henry R
Arroyo, Luis G
Allen-Vercoe, Emma
Gomes, Roberta G
Weese, J Scott
author_facet Costa, Marcio C
Stämpfli, Henry R
Arroyo, Luis G
Allen-Vercoe, Emma
Gomes, Roberta G
Weese, J Scott
author_sort Costa, Marcio C
collection PubMed
description BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to characterize changes in the fecal bacterial populations of healthy horses associated with the administration of frequently used antimicrobial drugs. RESULTS: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium IM, trimethoprim sulfadiazine (TMS) orally or to a control group. Treatment was given for 5 consecutive days and fecal samples were collected before drug administration (Day 1), at the end of treatment (Days 5), and on Days 14 and 30 of the trial. High throughput sequencing of the V4 region of the 16S rRNA gene was performed using an Illumina MiSeq sequencer. Significant changes of population structure and community membership were observed after the use of all drugs. TMS caused the most marked changes on fecal microbiota even at higher taxonomic levels including a significant decrease of richness and diversity. Those changes were mainly due to a drastic decrease of Verrucomicrobia, specifically the “5 genus incertae sedis”. Changes in structure and membership caused by antimicrobial administration were specific for each drug and may be predictable. Twenty-five days after the end of treatment, bacterial profiles were more similar to pre-treatment patterns indicating a recovery from changes caused by antimicrobial administration, but differences were still evident, especially regarding community membership. CONCLUSIONS: The use of systemic antimicrobials leads to changes in the intestinal microbiota, with different and specific responses to different antimicrobials. All antimicrobials tested here had some impact on the microbiota, but TMS significantly reduced bacterial species richness and diversity and had the greatest apparent impact on population structure, specifically targeting members of the Verrucomicrobia phylum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0335-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4323147
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43231472015-02-11 Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs Costa, Marcio C Stämpfli, Henry R Arroyo, Luis G Allen-Vercoe, Emma Gomes, Roberta G Weese, J Scott BMC Vet Res Research Article BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to characterize changes in the fecal bacterial populations of healthy horses associated with the administration of frequently used antimicrobial drugs. RESULTS: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium IM, trimethoprim sulfadiazine (TMS) orally or to a control group. Treatment was given for 5 consecutive days and fecal samples were collected before drug administration (Day 1), at the end of treatment (Days 5), and on Days 14 and 30 of the trial. High throughput sequencing of the V4 region of the 16S rRNA gene was performed using an Illumina MiSeq sequencer. Significant changes of population structure and community membership were observed after the use of all drugs. TMS caused the most marked changes on fecal microbiota even at higher taxonomic levels including a significant decrease of richness and diversity. Those changes were mainly due to a drastic decrease of Verrucomicrobia, specifically the “5 genus incertae sedis”. Changes in structure and membership caused by antimicrobial administration were specific for each drug and may be predictable. Twenty-five days after the end of treatment, bacterial profiles were more similar to pre-treatment patterns indicating a recovery from changes caused by antimicrobial administration, but differences were still evident, especially regarding community membership. CONCLUSIONS: The use of systemic antimicrobials leads to changes in the intestinal microbiota, with different and specific responses to different antimicrobials. All antimicrobials tested here had some impact on the microbiota, but TMS significantly reduced bacterial species richness and diversity and had the greatest apparent impact on population structure, specifically targeting members of the Verrucomicrobia phylum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0335-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-03 /pmc/articles/PMC4323147/ /pubmed/25644524 http://dx.doi.org/10.1186/s12917-015-0335-7 Text en © Costa et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Costa, Marcio C
Stämpfli, Henry R
Arroyo, Luis G
Allen-Vercoe, Emma
Gomes, Roberta G
Weese, J Scott
Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title_full Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title_fullStr Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title_full_unstemmed Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title_short Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
title_sort changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323147/
https://www.ncbi.nlm.nih.gov/pubmed/25644524
http://dx.doi.org/10.1186/s12917-015-0335-7
work_keys_str_mv AT costamarcioc changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs
AT stampflihenryr changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs
AT arroyoluisg changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs
AT allenvercoeemma changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs
AT gomesrobertag changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs
AT weesejscott changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs